Visipaque Side Effects
Generic name: iodixanol
Medically reviewed by Drugs.com. Last updated on Aug 6, 2024.
Note: This document provides detailed information about Visipaque Side Effects associated with iodixanol. Some dosage forms listed on this page may not apply specifically to the brand name Visipaque.
Applies to iodixanol: injection solution.
Important warnings
This medicine can cause some serious health issues
Injection route (solution)
Not for Intrathecal Use. Inadvertent intrathecal administration may cause death, convulsions/seizures, cerebral hemorrhage, coma, paralysis, arachnoiditis, acute renal failure, cardiac arrest, rhabdomyolysis, hyperthermia, and brain edema.
Serious side effects of Visipaque
Along with its needed effects, iodixanol (the active ingredient contained in Visipaque) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur while taking iodixanol:
Less common
- arm, back, or jaw pain
- chest pain, discomfort, tightness, or heaviness
- fainting
- fast or irregular heartbeat
- nausea
- sweating
Rare
- agitation
- blurred vision
- coma
- confusion
- cough
- decreased urine output
- depression
- difficulty breathing
- dilated neck veins
- dizziness
- dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
- fainting
- feeling of warmth
- headache
- hostility
- irregular breathing
- irritability
- lethargy
- muscle twitching
- noisy breathing
- rapid weight gain
- redness of the face, neck, arms, and occasionally, upper chest
- seizures
- severe or sudden headache
- stupor
- sudden loss of coordination
- sudden slurring of speech
- swelling of the face, hands, fingers, lower legs, ankles, or feet
- unusual tiredness or weakness
- vomiting
Incidence not known
- bloating
- chest tightness
- chills
- constipation
- cough
- darkened urine
- depressed mood
- difficulty swallowing
- dry skin and hair
- fast, irregular, pounding, or racing heartbeat or pulse
- feeling cold
- hair loss
- hives, itching, skin rash
- hoarseness or husky voice
- indigestion
- loss of appetite
- muscle cramps and stiffness
- nervousness
- no blood pressure or pulse
- pain, redness, or swelling at the injection site
- pains in the stomach, side, or abdomen, possibly radiating to the back
- pounding in the ears
- problems with speech or speaking
- puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
- sensitivity to heat
- slow or fast heartbeat
- stopping of the heart
- trouble sleeping
- unconsciousness
- weight gain or loss
- yellow eyes or skin
Other side effects of Visipaque
Some side effects of iodixanol may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Less common
- bad, unusual, or unpleasant (after) taste
- burning, crawling, itching, numbness, prickling, "pins and needles", tingling feeling
- change in taste
- diarrhea
- feeling of constant movement of self or surroundings
- itching or skin rash
- sensation of spinning
Rare
- acidic or sour stomach
- anxiety
- belching
- continuing ringing or buzzing or other unexplained noise in the ears
- decreased awareness or responsiveness
- dry mouth
- general feeling of discomfort or illness
- hearing loss
- heartburn
- restlessness
- severe sleepiness
- shaking
- stomach discomfort, upset, or pain
- transient, mild, pleasant aromatic odor
Incidence not known
- sneezing
For healthcare professionals
Applies to iodixanol: injectable solution.
General
Serious reactions as well as fatalities are only seen on very rare occasions. Serious adverse reactions may include acute/chronic renal failure, anaphylactic or anaphylactoid shock, hypersensitivity reaction followed by cardiac reactions (Kounis' syndrome), cardiac or cardio-respiratory arrest and myocardial infarction.[Ref]
Genitourinary
- Very common (10% or more): Vaginal hemorrhage (intrathecal)
- Uncommon (0.1% to 1%): Hematuria[Ref]
Cardiovascular
- Common (1% to 10%): Angina pectoris, chest pain
- Uncommon (0.1% to 1%): Arrhythmias, cardiac failure, conduction abnormalities, hypotension, myocardial infarction, flushing, peripheral ischemia.
- Rare (0.01% to 0.1%): Hypotension
- Very rare (less than 0.01%): Hypertension, ischemia
- Frequency not reported: Ventricular hypokinesia, myocardial ischemia, arterial spasm, thrombosis, thrombophlebitis, thrombocytopenia, cardiorespiratory arrest, spasm of coronary arteries, shock[Ref]
Dermatologic
- Common (1% to 10%): Nonurticarial rash, erythema, pruritus, rash, urticaria
- Uncommon (0.1% to 1%): Hematoma, increased sweating
- Very rare (less than 0.01%): Angioedema
- Frequency not reported: Severe pustular or bullous skin reactions, Stevens-Johnson syndrome, erythema multiforme, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, drug rash with eosinophilia and systemic symptoms, drug eruption, dermatitis allergic, skin exfoliation[Ref]
Gastrointestinal
- Common (1% to 10%): Nausea
- Uncommon (0.1% to 1%): Diarrhea, vomiting, dyspepsia
- Very rare (less than 0.01%): Abdominal pain, abdominal discomfort
- Frequency not reported: Acute pancreatitis, pancreatitis aggravated, salivary gland enlargement[Ref]
Local
- Common (1% to 10%): Injection site pain[Ref]
Nervous system
- Common (1% to 10%): Headache, migraine, paresthesia
- Uncommon (0.1% to 1%): Nervousness, dizziness, sensory disturbance, syncope, parosmia, cerebral vascular disorder, convulsions, hypoesthesia, stupor
- Very rare (less than 0.01%): Cerebrovascular accident, amnesia
- Frequency not reported: Disturbances in consciousness, coma, motor dysfunction, transient contrast induced encephalopathy (including hallucination), tremor
- Postmarketing reports: Dyskinesia[Ref]
Ocular
- Common (1% to 10%): Scotoma
- Uncommon (0.1% to 1%): Abnormal vision
- Frequency not reported: Transient blindness[Ref]
Other
- Common (1% to 10%): Vertigo
- Uncommon (0.1% to 1%): Edema, fatigue, malaise, tinnitus, feeling hot
- Rare (0.01% to 0.1%): Pain, pyrexia, shivering (chills), administration site reactions including
- Very rare (less than 0.01%): Feeling cold, asthenic conditions
- Frequency not reported: Iodism[Ref]
Hypersensitivity
- Uncommon (0.1% to 1%): Pharyngeal edema
- Frequency not reported: Anaphylactoid reaction, anaphylactoid shock[Ref]
Hypersensitivity reactions usually present as respiratory or cutaneous symptoms like dyspnea, rash, erythema, urticaria, pruritus, skin reaction, angioneurotic edema, hypotension, fever, laryngeal edema, bronchospasm or pulmonary edema. They may appear either immediately after the injection or up to a few days later.
Hypersensitivity reactions may occur irrespectively of the dose and mode of administration and mild symptoms may represent the first signs of a serious anaphylactoid reaction/shock.[Ref]
Psychiatric
- Uncommon (0.1% to 1%): Agitation, anxiety, insomnia, confusion[Ref]
Renal
- Uncommon (0.1% to 1%): Abnormal renal function, acute renal failure[Ref]
Respiratory
- Uncommon (0.1% to 1%): Asthma, bronchitis, dyspnea, pulmonary edema, rhinitis
- Rare (less than 0.1%): Cough
- Frequency not reported: Non-cardiogenic pulmonary edema, respiratory arrest, respiratory failure
- Postmarketing reports: Pulmonary embolism, respiratory depression[Ref]
Musculoskeletal
- Rare (less than 0.1%): Back pain
- Frequency not reported: Arthralgia
- Postmarketing reports: Polymyalgia rheumatica[Ref]
Hematologic
- Postmarketing reports: Hemorrhage[Ref]
Metabolic
- Postmarketing reports: Hypoglycemia[Ref]
References
1. (2001) "Product Information. Visipaque (iodixanol)." Nycomed Inc
2. Cerner Multum, Inc. "UK Summary of Product Characteristics."
3. Cerner Multum, Inc. "Australian Product Information."
More about Visipaque (iodixanol)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Latest FDA alerts (2)
- Dosage information
- During pregnancy
- Generic availability
- Drug class: non-ionic iodinated contrast media
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Visipaque side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.